Forum Archive Index - January 2003

Please note usage of the Forum is subject to the Terms & Conditions.

Messages by Date [	Next by Date	Previous by Date ]
Messages by Thread [	Next by Thread	Previous by Thread ]
Post to the Forum [	New message	Reply to this message ]

Printable version

Re: Re: [sharechat] GEN

From:	"G Stolwyk" <stolwyk@wave.co.nz>
Date:	Sat, 18 Jan 2003 23:50:23 +1300

Continued:

Yes, I used to collect a lot of drug data for PTD investors but haven't bothered lately. Too busy with NRT drugs now.

I would say that PTD's Anti-TNF molecule is the secret to this (Enbrel would deny that and I am not sure if PTD will "test" this later on).

From the article:
" Patients in the psoriasis trial were injected twice a week with double the amount of Enbrel, 50 milligrams, as the dose for which the drug is approved for rheumatoid arthritis patients".

Comment: Boy, that is a strong delivery!

I doubt if Gen's drugs will be that powerful (an opinion only).

Gerry

Messages by Date [	Next by Date:	Re: Re: Re: [sharechat] GEN G Stolwyk
	Previous by Date:	Re: [sharechat] GEN G Stolwyk ]
Messages by Thread [	Next by Thread:	Re: Re: Re: [sharechat] GEN G Stolwyk
	Previous by Thread:	Re: [sharechat] GEN G Stolwyk ]
Post to the Forum [	New message	Reply to this message ]